Clinical Trials
3 trialsNCT01582295 2017-05-25
XL184 For Relapsed/Refractory Multiple Myeloma (MM) With Bone Disease
Massachusetts General Hospital
Phase 1 Completed
NCT02442063 2016-11-30
Phase Ib Study of Radium Ra 223 Dichloride in Combination With Paclitaxel in Cancer Subjects With Bone Lesions
Bayer
Phase 1 Completed
NCT00741377 2013-02-18
A Study to Assess BHQ880 in Combination With Zoledronic Acid in Relapsed or Refractory Myeloma Patients
Novartis
Phase 1 Completed